For the Quarter Ending September 2025
North America
• In United States, the 1,3 Cyclohexanedione Price Index fell in Q3 2025, influenced by easing feedstock and slowing industrial production.
• 1,3 Cyclohexanedione production costs were impacted as Resorcinol feedstock eased in Q3 2025 due to elevated importer stocks.
• Producer Price Index (PPI) increased 3.3% in July 2025 and 2.6% in August 2025, reflecting fluctuating input costs.
• Demand from the pharmaceutical sector strengthened in Q3 2025, driven by increased drug approvals and business deals.
• Industrial production growth slowed significantly from 1.4% in July to 0.1% in September 2025, impacting overall chemical demand.
• Consumer Price Index (CPI) increased from 2.7% in July to 3% in September 2025, indicating broader inflationary pressures.
• Retail sales increased 3.9% in July 2025 and 5% in August 2025, supporting consumer-facing end-product demand.
• US natural gas prices averaged higher in Q3 2025 but eased in September 2025, affecting energy-related production costs.
Why did the price of 1,3 Cyclohexanedione change in September 2025 in North America?
• Resorcinol feedstock costs eased in Q3 2025 due to elevated importer and distributor inventories.
• Industrial production growth slowed to 0.1% in September 2025, indicating reduced demand from end-use sectors.
• Producer Price Index (PPI) increased 2.6% in August 2025, reflecting continued, albeit slower, increases in input costs.
APAC
• In China, the 1,3 Cyclohexanedione Price Index fell quarter-over-quarter in Q3 2025, driven by declining production costs.
• The 1,3 Cyclohexanedione Price Forecast indicates continued pressure due to ample supply and easing feedstock expenses.
• Production costs for 1,3 Cyclohexanedione decreased as the Producer Price Index fell -3.6% in July and -2.3% in September 2025.
• Demand for 1,3 Cyclohexanedione strengthened, with industrial production growing 5.7% in July and 6.5% in September 2025.
• Manufacturing activity, a key demand driver, showed recovery in Q3 2025, moving from contracting to recovering.
• Pharmaceutical sector growth exhibited robust expansion in Q3 2025, boosting 1,3 Cyclohexanedione consumption.
• Benzene feedstock costs eased slightly in Q3 2025, contributing to lower overall 1,3 Cyclohexanedione production expenses.
• Overall chemical capacity expanded significantly in China during 2025, intensifying market competition for 1,3 Cyclohexanedione.
Why did the price of 1,3 Cyclohexanedione change in September 2025 in APAC?
• Producer Price Index declined -2.3% in September 2025, reducing raw chemical material costs.
• Benzene feedstock costs eased slightly in Q3 2025, lowering 1,3 Cyclohexanedione manufacturing expenses.
• Increased chemical capacity in China intensified competition, contributing to downward price pressure in Q3 2025.
Europe
• In Germany, the 1,3 Cyclohexanedione Price Index fell in Q3 2025, due to weakening demand and declining basic chemical producer prices.
• Production costs for 1,3 Cyclohexanedione faced pressure from persistently high energy and raw material costs in Q3 2025.
• Demand for 1,3 Cyclohexanedione weakened, reflecting a -1% decline in industrial production in September 2025.
• The 1,3 Cyclohexanedione Price Index reflected downward pressure from contracting chemical production in Germany in Q3 2025.
• The pharmaceutical sector, a key end-market for 1,3 Cyclohexanedione, showed firming output in Q3 2025.
• German chemical exports, including 1,3 Cyclohexanedione, weakened in Q3 2025, with sales outside Europe declining.
• Producer prices for basic chemicals decreased by -2.2% in September 2025, suggesting lower input costs.
• Consumer Price Index rose 2.4% in September 2025, influencing end-product demand, with unemployment at 3.9%.
Why did the price of 1,3 Cyclohexanedione change in September 2025 in Europe?
• Weakening chemical product demand and -1% industrial production decline in September 2025.
• Basic chemical producer prices decreased -2.2% in September 2025, impacting 1,3 Cyclohexanedione input costs.
• Weakened German chemical exports and declining non-European sales in Q3 2025 impacted market balance.
